Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of research

International Journal of Epidemiology

Volumn 38, Issue 5, 2009, Pages 1255-1264

  Kirkbride, J B ^a   Croudace, T ^a   Brewin, J ^b   Donoghue, K ^c   Mason, P ^d   Glazebrook, C ^e   Medley, I ^f   Harrison, G ^g   Cooper, J E ^e   Doody, G A ^e   Jones, P B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NOTTINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^c Duncan Macmillan House   (United Kingdom)

^d St Catherine's Hospital   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f Mandala Centre   (United Kingdom)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Demographic factors; Epidemiology; Incidence; Psychotic disorder; Schizophrenia; Time

Indexed keywords

DEMOGRAPHIC SURVEY; DISEASE INCIDENCE; DISEASE PREVALENCE; EPIDEMIOLOGY; MENTAL HEALTH; RESEARCH WORK; RISK FACTOR; TIME SERIES ANALYSIS; TOXIC SUBSTANCE;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSIVE PSYCHOSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; ILLNESS TRAJECTORY; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MANIC PSYCHOSIS; MENTAL DISEASE; MENTAL HEALTH RESEARCH; MORBIDITY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SCHIZOPHRENIA; STANDARDIZATION; SUBSTANCE ABUSE; SUBSTANCE INDUCED PSYCHOSIS; UNITED KINGDOM;

ADOLESCENT; ADULT; EVIDENCE-BASED MEDICINE; FEMALE; GREAT BRITAIN; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SOCIAL ENVIRONMENT; YOUNG ADULT;

ENGLAND; EURASIA; EUROPE; NOTTINGHAM [ENGLAND]; UNITED KINGDOM; WESTERN EUROPE;

EID: 70349873833     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyn168     Document Type: Article

References (35)

1. Der G, Gupta S, Murray RM. Is schizophrenia disappearing? Lancet 1990;335:513-16.
2. Eagles JM, Hunter D, McCance C. Decline in the Diagnosis of Schizophrenia among 1st Contacts with Psychiatric-Services in Northeast Scotland, 1969-1984. Br J Psychiatry 1988;152:793-98.
3. Geddes JR, Black RJ, Whalley LJ, Eagles JM. Persistence of the decline in the diagnosis of schizophrenia among first admissions to Scottish hospitals from 1969 to 1988. Br J Psychiatry 1993;163:620-26.
4. Munk-Jorgensen P, Mortensen PB. Is schizophrenia really on the decrease? Eur Arch Psychiatry Clin Neurosci 1993;242:244-47.
5. Osby U, Hammar N, Brandt L et al. Time trends in first admissions for schizophrenia and paranoid psychosis in Stockholm County, Sweden. Schizophr Res 2001; 47:247-54.
6. Kendell RE, Malcolm DE, Adams W. The problem of detecting changes in the incidence of schizophrenia. Br J Psychiatry 1993;162:212-18.
7. Bresnahan M, Boydell J, Murray R, Susser E. Temporal variation in the incidence, course and outcome of schizophrenia. In: Murray R, Jones PB, Susser E, van Os J, Cannon M (eds). The Epidemiology of Schizophrenia Cambridge: Cambridge University Press, 2003.
8. Harrison G, Cooper JE, Gancarczyk R. Changes in the administrative incidence of schizophrenia. Br J Psychiatry 1991;159:811-16.
9. Brewin J, Cantwell R, Dalkin T et al. Incidence of schizophrenia in Nottingham - A comparison of two cohorts, 1978-80 and 1992-94. Br J Psychiatry 1997; 171:140-44.
10. Castle D, Wessely S, Der G, Murray RM. The incidence of operationally defined schizophrenia in Camberwell, 1965-84. Br J Psychiatry 1991;159:790-94.
11. Boydell J, Van Os J, Lambri M et al. Incidence of schizophrenia in south-east London between 1965 and 1997. Br J Psychiatry 2003; 182:45-49.
12. Boydell J, van Os J, McKenzie K et al. Incidence of schizophrenia in ethnic minorities in London: Ecological study into interactions with environment. BMJ 2001;323:1336-38.
13. Fearon P, Kirkbride JB, Morgan C et al. Incidence of schizophrenia and other psychoses in ethnic minority groups: Results from the MRC AESOP Study. Psychol Med 2006;36:1541-50.
14. van Os J, Takei N, Castle DJ et al. The incidence of mania: Time trends in relation to gender and ethnicity. Soc Psychiatry Psychiatr Epidemiol 1996;31:129-36.
15. Jablensky A, Sartorius N, Ernberg G et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monograph Supplement 1992; 20:1-97.
16. Cooper JE, Goodhead D, Craig T, Harris M, Howat J, Korer J. The incidence of schizophrenia in Nottingham. Br J Psychiatry 1987; 151:619-26.
17. Kirkbride JB, Fearon P, Morgan C et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-Center ÆSOP Study. Arch Gen Psychiatry 2006;63:250-58.
18. Wing JK, Cooper JE, Sartorius N. The Measurement and Classification of Psychiatric Symptoms. Cambridge & London: Cambridge University Press, 1974.
19. WHO. Schedule for Clinical Assessment in Neuropsychiatry. Geneva: WHO, 1992.
20. Andreasen NC. Negative symptoms in schizophrenia. Definition and reliability. Arch of Gen Psychiatry 1982;39:784-88.
21. WHO. International Classification of Diseases. World Health Organisation. 10th edn. Geneva: World Health Organisation, 1994.
22. OPCS/GRO(S). Undercoverage in Great Britain: 1991 Census User Guide 58. London, 1994.
23. Munk-Jorgensen P, Mortensen PB. Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971-87. Br J Psychiatry 1992;161:489-95.
24. Suvisaari JM, Haukka JK, Tanskanen AJ, Lonnqvist JK. Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965. Archf Gen Psychiatry 1999;56:733-40.
25. Allardyce J, Morrison G, Van Os J, Kelly J, Murray RM, McCreadie RG. Schizophrenia is not disappearing in south-west Scotland. Br J Psychiatry 2000;177:38-41.
26. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: The distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2004;2. Available at http://www.ncbi.nlm.nih.gov/pubmed/15115547?dopt= AbstractPlus&holding=f1000,f1000m,isrctn.
27. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. BMJ 2002;325:1212-13.
28. Moore THM, Zammit S, Lingford-Hughes A et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. The Lancet 2007;370:319-28.
29. Cantwell R, Brewin J, Glazebrook C et al. Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry 1999;174 150-53.
30. Ramsay M, Partridge S. Drug misuse declared in 1998: Results from the British Crime Survey. London: Home Office, 1999.
31. Murphy R, Roe S. Drug misuse declared: Findings from the 2006/7 British Crime Survey. London: Home Office, 2007.
32. Bone C, Waldron SJ. New trends in illiait cannabis cultivation in the United Kingdom of Breat Britain and Northern Ireland. Bull Narcotics 1998;50:117-28.
33. Kirkbride JB, Morgan C, Fearon P, Dazzan P, Murray RM, Jones PB. Neighbourhood-level effects on psychoses: Re-examining the role of context. Psychol Med 2007;37:1413-25.
34. Caspi A, Moffitt TE, Cannon M et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005;57:1117-27.
35. Hickman M, Vickerman P, Macleod J, Kirkbride JB, Jones PB. Cannabis and Schizophrenia: Model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 2007;102:597-606.